NCT07093515View on ClinicalTrials.gov

Biomarkers, Risk Assessment, Imaging, and Neurodegeneration in Cerebral Small Vessel Disease (BRAIN-CSVD)

Not yet recruitingOBSERVATIONAL

Enrollment

500

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

December 30, 2030

Study Completion Date

December 30, 2032

Conditions

Cerebral Small Vessel Disease

Interventions

OTHER

No intervention

All Listed Sponsors

lead

Zhejiang Hospital

OTHER

NCT07093515 - Biomarkers, Risk Assessment, Imaging, and Neurodegeneration in Cerebral Small Vessel Disease (BRAIN-CSVD) | Biotech Hunter | Biotech Hunter